Artelo Biosciences Inc [NASDAQ: ARTL] gained 95.43% on the last trading session, reaching $71420.0 price per share at the time.
Artelo Biosciences Inc represents 3.28 million in outstanding shares, while the company has a total market value of $7.25 million with the latest information. ARTL stock price has been found in the range of $12.6 to $25.58.
If compared to the average trading volume of 71.42K shares, ARTL reached a trading volume of 26905217 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Artelo Biosciences Inc [ARTL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ARTL shares is $36.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ARTL stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Artelo Biosciences Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on February 12, 2021.
The Price to Book ratio for the last quarter was 66.78, with the Price to Cash per share for the same quarter was set at 1.37.
Trading performance analysis for ARTL stock
Artelo Biosciences Inc [ARTL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 125.68. With this latest performance, ARTL shares gained by 117.90% in over the last four-week period, additionally plugging by 128.01% over the last 6 months – not to mention a rise of 108.65% in the past year of trading.
Artelo Biosciences Inc [ARTL]: A deeper dive into fundamental analysis
Return on Equity for this stock declined to -140.10%, with Return on Assets sitting at -140.10%.
Artelo Biosciences Inc [ARTL]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ARTL. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Artelo Biosciences Inc go to 48.77%.
An analysis of Institutional ownership at Artelo Biosciences Inc [ARTL]
There are presently around $2.64%, or 2.66% of ARTL stock, in the hands of institutional investors.
